Edyta Maria Urbanska

12PUBLICATIONS
14CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Medical biotechnology diagnostics (incl. biosensors)Solid tumoursMolecular targetsLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 27, 2026
Novel Co-Occurrence of Germline EGFR p.V843I and Somatic EGFR Exon 19 Deletion in NSCLC: Insights into Reduced Sensitivity to EGFR-TKIs.

|Jan 10, 2026
Improvement of Diagnostics in NSCLC Patients with MET Exon 14 Mutations Using Complementary DNA/RNA-NGS and Identification of Two Novel Exonic Splicing Mutations.

Edyta Maria Urbanska, Thomas Koed Doktor, Linea Cecilie Melchior

|Jul 12, 2025
Refining Criteria for Choosing the First-Line Treatment for Real-World Patients with Advanced ALK-Rearranged NSCLC.

Edyta Maria Urbanska, Peter Rindom Koffeldt, Morten Grauslund

|Oct 21, 2024
ALK-tyrosine kinase inhibitor intrinsic resistance due to de novo MET-amplification in metastatic ALK-rearranged non-small cell lung cancer effectively treated by alectinib-crizotinib combination-case report.

Edyta M Urbanska, Morten Grauslund, Siv M S Berger

|May 31, 2024
Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosis.

Jon Lykkegaard Andersen, Jakob Sidenius Johansen, Edyta Maria Urbanska

|Sep 09, 2023
Real-World Data on Combined EGFR-TKI and Crizotinib Treatment for Acquired and De Novo MET Amplification in Patients with Metastatic EGFR-Mutated NSCLC.

Edyta M Urbanska, Morten Grauslund, Peter R Koffeldt

Pageof 2

Frequent Collaborators

10 joint publications

Eric Santoni-Rugiu

7 joint publications

Jens Benn Sørensen

4 joint publications

Morten Grauslund

3 joint publications

Peter Rindom Koffeldt